137 related articles for article (PubMed ID: 30550768)
1. Progesterone for preterm birth prevention: the importance of informed consent.
Urato AC
Am J Obstet Gynecol; 2019 Mar; 220(3):290. PubMed ID: 30550768
[No Abstract] [Full Text] [Related]
2. Reassessing Preterm Birth Prevention After the Withdrawal of 17-α Hydroxyprogesterone Caproate.
Heyborne K
Obstet Gynecol; 2023 Sep; 142(3):493-501. PubMed ID: 37441790
[TBL] [Abstract][Full Text] [Related]
3. Progesterone effects on vaginal cytokines in women with a history of preterm birth.
Garry DJ; Baker DA; Persad MD; Peresleni T; Kocis C; Demishev M
PLoS One; 2018; 13(12):e0209346. PubMed ID: 30596707
[TBL] [Abstract][Full Text] [Related]
4. The association among cytochrome P450 3A, progesterone receptor polymorphisms, plasma 17-alpha hydroxyprogesterone caproate concentrations, and spontaneous preterm birth.
Bustos ML; Caritis SN; Jablonski KA; Reddy UM; Sorokin Y; Manuck T; Varner MW; Wapner RJ; Iams JD; Carpenter MW; Peaceman AM; Mercer BM; Sciscione A; Rouse DJ; Ramin SM;
Am J Obstet Gynecol; 2017 Sep; 217(3):369.e1-369.e9. PubMed ID: 28522317
[TBL] [Abstract][Full Text] [Related]
5. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
O'Brien JM; Lewis DF
Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial of intramuscular versus vaginal progesterone for the prevention of recurrent preterm birth.
Elimian A; Smith K; Williams M; Knudtson E; Goodman JR; Escobedo MB
Int J Gynaecol Obstet; 2016 Aug; 134(2):169-72. PubMed ID: 27168167
[TBL] [Abstract][Full Text] [Related]
7. Obstetric Indications for Progestin Therapy.
Boelig RC
Obstet Gynecol Clin North Am; 2023 Mar; 50(1):101-107. PubMed ID: 36822696
[TBL] [Abstract][Full Text] [Related]
8. Deus ex Makena?
Silver RM; Cunningham FG
Obstet Gynecol; 2011 Jun; 117(6):1263-1265. PubMed ID: 21471852
[No Abstract] [Full Text] [Related]
9. Progestogens in singleton gestations with preterm prelabor rupture of membranes: a systematic review and metaanalysis of randomized controlled trials.
Quist-Nelson J; Parker P; Mokhtari N; Di Sarno R; Saccone G; Berghella V
Am J Obstet Gynecol; 2018 Oct; 219(4):346-355.e2. PubMed ID: 29614278
[TBL] [Abstract][Full Text] [Related]
10. Response to 17-alpha hydroxyprogesterone caproate.
Frappaolo A; Vadnais M
Am J Obstet Gynecol; 2018 Aug; 219(2):217. PubMed ID: 29698618
[No Abstract] [Full Text] [Related]
11. Efficacy of progesterone for prevention of preterm birth.
Sykes L; Bennett PR
Best Pract Res Clin Obstet Gynaecol; 2018 Oct; 52():126-136. PubMed ID: 30266582
[TBL] [Abstract][Full Text] [Related]
12. Utilization, Cost, and Outcome of Branded vs Compounded 17-Alpha Hydroxyprogesterone Caproate in Prevention of Preterm Birth.
Fried I; Beam AL; Kohane IS; Palmer NP
JAMA Intern Med; 2017 Nov; 177(11):1689-1690. PubMed ID: 28973537
[TBL] [Abstract][Full Text] [Related]
13. 17-alpha hydroxyprogesterone caproate for preterm birth prevention: Where have we been, how did we get here, and where are we going?
Manuck TA
Semin Perinatol; 2017 Dec; 41(8):461-467. PubMed ID: 28947068
[TBL] [Abstract][Full Text] [Related]
14. Clinical Application of Progesterone for the Prevention of Preterm Birth, 2016.
Goodnight W
Am J Perinatol; 2016 Feb; 33(3):253-7. PubMed ID: 26788788
[TBL] [Abstract][Full Text] [Related]
15. Operationalizing 17α-Hydroxyprogesterone Caproate to Prevent Recurrent Preterm Birth: Definitions, Barriers, and Next Steps.
Owens L; Prager S
Obstet Gynecol; 2017 May; 129(5):945. PubMed ID: 28426603
[No Abstract] [Full Text] [Related]
16. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.
Shambhavi S; Bagga R; Bansal P; Kalra J; Kumar P
J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230
[TBL] [Abstract][Full Text] [Related]
17. Progesterone has no place in the prevention of preterm delivery: AGAINST: A call for a measured response to the OPPTIMUM trial.
Eichelberger KY; Manuck TA
BJOG; 2016 Aug; 123(9):1511. PubMed ID: 27440593
[No Abstract] [Full Text] [Related]
18. Letter: re: Jain et al., Progesterone for Prevention of Spontaneous Preterm Birth.
Ramji N
J Obstet Gynaecol Can; 2020 Oct; 42(10):1200-1201. PubMed ID: 33059879
[No Abstract] [Full Text] [Related]
19. A question about the reliability of a recent trial of progesterone for preterm birth prevention, published in Acta.
Katsanevakis E; Mol BW; Thornton J
Acta Obstet Gynecol Scand; 2020 Mar; 99(3):426. PubMed ID: 31721143
[No Abstract] [Full Text] [Related]
20. Does adjunctive use of progesterone in women with cerclage improve prevention of preterm birth?
Sinkey RG; Garcia MR; Odibo AO
J Matern Fetal Neonatal Med; 2018 Jan; 31(2):202-208. PubMed ID: 28068860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
